NO942372L - Propensyrederivater - Google Patents
PropensyrederivaterInfo
- Publication number
- NO942372L NO942372L NO942372A NO942372A NO942372L NO 942372 L NO942372 L NO 942372L NO 942372 A NO942372 A NO 942372A NO 942372 A NO942372 A NO 942372A NO 942372 L NO942372 L NO 942372L
- Authority
- NO
- Norway
- Prior art keywords
- propenoic acid
- acid derivative
- antagonism
- meanings
- sulfur
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Nye propensyrederivater som utviser adenosin Al antagonisme er definert ved den genrelle formel (I): hvor A representerer en aromatisk ring, X, Y og Z represen- terer hver oksygen, svovel, nitrogen eller karbon, og hvor R1, R2, R3, R', R5, R6, R7, R6 og B har en rekke angitte betydninger, eller et farmakologisk tålbart salt derav.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17727893 | 1993-06-24 | ||
JP20290393 | 1993-07-23 | ||
JP22792493 | 1993-08-21 | ||
JP23718893 | 1993-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942372D0 NO942372D0 (no) | 1994-06-22 |
NO942372L true NO942372L (no) | 1994-12-27 |
Family
ID=27474760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942372A NO942372L (no) | 1993-06-24 | 1994-06-22 | Propensyrederivater |
Country Status (12)
Country | Link |
---|---|
US (2) | US5541213A (no) |
EP (1) | EP0630894A1 (no) |
JP (1) | JP3815691B2 (no) |
KR (1) | KR950000693A (no) |
CN (1) | CN1111622A (no) |
AU (1) | AU683460B2 (no) |
CA (1) | CA2126020A1 (no) |
FI (1) | FI942923A (no) |
HU (1) | HUT71106A (no) |
NO (1) | NO942372L (no) |
NZ (2) | NZ272142A (no) |
TW (1) | TW278074B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6429221B1 (en) * | 1994-12-30 | 2002-08-06 | Celgene Corporation | Substituted imides |
JPH11513022A (ja) * | 1995-08-02 | 1999-11-09 | スミスクライン・ビーチャム・コーポレイション | エンドセリンレセプターアンタゴニスト |
WO1997026246A1 (en) * | 1996-01-16 | 1997-07-24 | Warner-Lambert Company | Substituted histidine inhibitors of protein farnesyltransferase |
EP0925297A1 (en) * | 1996-02-01 | 1999-06-30 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
JP2000504013A (ja) * | 1996-02-01 | 2000-04-04 | スミスクライン・ビーチャム・コーポレイション | エンドセリンレセプターアンタゴニスト |
ID18983A (id) * | 1996-12-04 | 1998-05-28 | Lilly Co Eli | Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia |
US20060211731A1 (en) * | 1999-05-05 | 2006-09-21 | Les Laboratories Servier | New substituted pyridine or piperidine compounds |
WO2003072554A1 (en) | 2002-02-28 | 2003-09-04 | Takeda Chemical Industries, Ltd. | Azole compounds |
US6727241B2 (en) * | 2002-06-12 | 2004-04-27 | Chemocentryx | Anti-inflammatory compositions and methods of use |
WO2004039365A1 (en) | 2002-11-01 | 2004-05-13 | Takeda Pharmaceutical Company Limited | Agent for preventing or treating neuropathy |
DE10300124A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Verfahren zur Herstellung von Arylalkinen |
US20100029724A1 (en) * | 2006-07-19 | 2010-02-04 | Takeda Pharmaceutical Company Limited | Screening method |
EP1939180A1 (en) * | 2006-12-20 | 2008-07-02 | sanofi-aventis | Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase |
DE102008039082A1 (de) * | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Azabicyclisch-substituierte 5-Aminopyrazole und ihre Verwendung |
DE102008039083A1 (de) * | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Aminopyrazole und ihre Verwendung |
CA2877474A1 (en) * | 2011-06-20 | 2012-12-27 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
US9428490B2 (en) * | 2011-07-29 | 2016-08-30 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
PL2736887T3 (pl) | 2011-07-29 | 2018-03-30 | Karyopharm Therapeutics, Inc. | Modulatory transportu jądrowego zawierające ugrupowanie hydrazydu i ich zastosowania |
KR102095429B1 (ko) | 2012-05-09 | 2020-03-31 | 바이오젠 엠에이 인코포레이티드 | 핵 수송 조절인자 및 이의 용도 |
WO2014144772A1 (en) | 2013-03-15 | 2014-09-18 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using crm1 inhibitors |
CN110386919B (zh) | 2013-06-21 | 2023-07-14 | 卡尔约药物治疗公司 | 核转运调节剂及其用途 |
EP4112615A1 (en) | 2014-08-15 | 2023-01-04 | Karyopharm Therapeutics Inc. | Compositions comprising one crystalline form of selinexor |
WO2017117535A1 (en) | 2015-12-31 | 2017-07-06 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
EP3397633A1 (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
WO2018098472A1 (en) | 2016-11-28 | 2018-05-31 | Karyopharm Therapeutics Inc. | Crm1 inhibitors for treating epilepsy |
CN111943900B (zh) * | 2019-05-17 | 2023-11-17 | 宁夏苏融达化工有限公司 | 异噁唑啉衍生物及其在农业中的应用 |
WO2024125464A1 (en) * | 2022-12-11 | 2024-06-20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Tetrahydroisoquinolin-one derivatives, preparation methods and medicinal uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3542661A1 (de) * | 1985-12-03 | 1987-06-04 | Bayer Ag | Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung |
US4743238A (en) * | 1986-03-17 | 1988-05-10 | Malcolm Nicol & Co. | Wetness indicating hot-melt adhesives |
US4769466A (en) * | 1987-02-06 | 1988-09-06 | Pennwalt Corporation | 2-aminoacetamide pyridinyl derivatives |
US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
CA2060138A1 (en) * | 1991-01-29 | 1992-07-30 | Youichi Shiokawa | New use of the adenosine antagonist |
GB9107513D0 (en) * | 1991-04-10 | 1991-05-29 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
-
1994
- 1994-06-10 US US08/258,634 patent/US5541213A/en not_active Expired - Lifetime
- 1994-06-15 EP EP94109221A patent/EP0630894A1/en not_active Withdrawn
- 1994-06-16 CA CA002126020A patent/CA2126020A1/en not_active Abandoned
- 1994-06-17 FI FI942923A patent/FI942923A/fi not_active Application Discontinuation
- 1994-06-22 NZ NZ272142A patent/NZ272142A/en unknown
- 1994-06-22 NO NO942372A patent/NO942372L/no unknown
- 1994-06-22 NZ NZ260816A patent/NZ260816A/en unknown
- 1994-06-23 AU AU64878/94A patent/AU683460B2/en not_active Ceased
- 1994-06-24 JP JP16594794A patent/JP3815691B2/ja not_active Expired - Fee Related
- 1994-06-24 KR KR1019940014602A patent/KR950000693A/ko not_active Application Discontinuation
- 1994-06-24 CN CN94107564A patent/CN1111622A/zh active Pending
- 1994-06-24 HU HU9401917A patent/HUT71106A/hu unknown
- 1994-07-13 TW TW083106343A patent/TW278074B/zh active
-
1995
- 1995-04-11 US US08/419,941 patent/US5606073A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI942923A (fi) | 1994-12-25 |
TW278074B (no) | 1996-06-11 |
EP0630894A1 (en) | 1994-12-28 |
HU9401917D0 (en) | 1994-09-28 |
US5606073A (en) | 1997-02-25 |
HUT71106A (en) | 1995-11-28 |
NO942372D0 (no) | 1994-06-22 |
CN1111622A (zh) | 1995-11-15 |
JPH07118237A (ja) | 1995-05-09 |
JP3815691B2 (ja) | 2006-08-30 |
FI942923A0 (fi) | 1994-06-17 |
AU683460B2 (en) | 1997-11-13 |
NZ260816A (en) | 1996-11-26 |
CA2126020A1 (en) | 1994-12-25 |
AU6487894A (en) | 1995-01-05 |
NZ272142A (en) | 1996-11-26 |
US5541213A (en) | 1996-07-30 |
KR950000693A (ko) | 1995-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942372L (no) | Propensyrederivater | |
DK0487071T3 (da) | Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse | |
DK0427549T3 (da) | Heterocykliske oxy-phenoxyeddikesyrederivater og deres anvendelse som herbicider | |
NO953305L (no) | Antranilsyrederivat | |
NO965524L (no) | Tri-substituerte fenylderivater anvendelige som PDE IV inhibitorer | |
NO179904C (no) | Kondenserte heterocykliske forbindelser og deres anvendelse | |
DE69615802D1 (de) | Heterocyclische substituierte Benzofuran-Harnstoffe | |
DK271388A (da) | Oxetanocinereller farmakologisk acceptable salte deraf samt deres anvendelse | |
ATE53585T1 (de) | Penemverbindungen, ihre herstellung und verwendung. | |
DK0394889T3 (da) | Heterocycliske dioner som pesticider og plantevækstregulatorer | |
ATE13178T1 (de) | 2-oxoazetidin-derivate, ihre herstellung und verwendung. | |
ES8704888A1 (es) | Procedimiento para preparar un derivado fungicida de n-(2-cloro-4-nitrofenil)-bencenosulfonamida | |
NO885714L (no) | Fremgangsmaate for fremstilling av propoksybenzenderivater. | |
DK0696585T3 (da) | Nyt bisoxadiazolidinderivat | |
ATE217529T1 (de) | Antivirale triazazyklododecane | |
ES2097124T3 (es) | Derivados del s-triazolo(3,4-i)purina. | |
DK0554794T3 (da) | Aminobenzoesyrederivater | |
NO870176L (no) | Nye forbindelser og fremgangsmaater. | |
IT1241988B (it) | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono | |
MX9605994A (es) | Formilaminofenilsulfonilureas, metodos para prepararlos y su uso como herbicidas y reguladores de crecimiento de la plantas. | |
BR8903043A (pt) | Processo para preparacao de compostos | |
NO20010332L (no) | Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter | |
TH4572A (th) | เบนโซอิลยูเรียชนิดใหม่ |